|
US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
JP4575592B2
(ja)
*
|
1997-11-14 |
2010-11-04 |
パシラ ファーマシューティカルズ インコーポレーテッド |
多小胞リポソームの製造
|
|
PE20000601A1
(es)
|
1998-03-23 |
2000-07-25 |
Gen Mills Inc |
Encapsulado de componentes en productos comestibles
|
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
|
PT1225897E
(pt)
*
|
1999-11-01 |
2005-01-31 |
John Rhodes |
Composicao para o tratamento da obstipacao e do sindroma do intestino irritavel
|
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
WO2005039531A1
(en)
*
|
2003-10-10 |
2005-05-06 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
WO2002011768A1
(en)
*
|
2000-08-03 |
2002-02-14 |
Antares Pharma Ipl Ag |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
CA2341952A1
(en)
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US7507717B2
(en)
|
2002-12-02 |
2009-03-24 |
Xenome Ltd. |
Type II chi-conotoxin peptides (noradrenaline transporter inhibitors)
|
|
WO2004050690A1
(en)
|
2002-12-02 |
2004-06-17 |
Xenome Ltd |
NOVEL χ-CONOTOXIN PEPTIDES (-I)
|
|
US8337891B2
(en)
|
2003-07-03 |
2012-12-25 |
Sucampo Ag |
Enteric coated composition comprising prostaglandin analogs as chloride channel opener
|
|
PL2446881T3
(pl)
|
2003-07-24 |
2014-08-29 |
Glaxosmithkline Llc |
Folie rozpuszczające się w jamie ustnej
|
|
WO2005021013A1
(ja)
*
|
2003-09-01 |
2005-03-10 |
Earthus, Inc. |
β−ヒドロキシ短〜中鎖脂肪酸重合体
|
|
US20070191815A1
(en)
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
CA2571554A1
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
WO2006125642A1
(en)
|
2005-05-27 |
2006-11-30 |
Antares Pharma Ipl Ag |
Methods and apparatus for transdermal or transmucosal application of testosterone
|
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
|
EP1931417A2
(en)
*
|
2005-09-30 |
2008-06-18 |
Transcutaneous Technologies Inc. |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
|
EP1928539A1
(en)
*
|
2005-09-30 |
2008-06-11 |
Tti Ellebeau, Inc. |
Functionalized microneedles transdermal drug delivery systems, devices, and methods
|
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
|
NZ571460A
(en)
|
2006-04-21 |
2010-10-29 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
JP5504534B2
(ja)
|
2007-03-30 |
2014-05-28 |
有限会社アーザス |
ケトン体生成促進剤組成物
|
|
ES2521494T3
(es)
*
|
2007-04-02 |
2014-11-12 |
Parkinson's Institute |
Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
|
|
MX2009012273A
(es)
*
|
2007-05-18 |
2010-04-09 |
Tti Ellebeau Inc |
Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
|
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
|
DK2654738T3
(en)
*
|
2010-12-21 |
2018-07-23 |
Fertin Pharma As |
CHEESE GUM COMPOSITION COMPREHENSIVE CROSS-POLYACRYLIC ACID
|
|
US20130017259A1
(en)
*
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
|
CA2876540C
(en)
*
|
2012-06-15 |
2022-11-29 |
Conaris Research Institute Ag |
A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
|
|
AU2012386221A1
(en)
|
2012-07-26 |
2015-02-26 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
|
JP6895752B2
(ja)
|
2013-12-13 |
2021-06-30 |
コナリス リサーチ インスティチュート アーゲー |
ニコチン酸および／またはニコチンアミドを含む、腸内微生物叢を改変することにより血中脂質レベルに有益に影響を及ぼすための医薬組成物
|
|
ES2716115T3
(es)
|
2013-12-13 |
2019-06-10 |
Conaris Res Institute Ag |
Una composición farmacéutica que contiene conbinaciones de nicotinamida y ácido 5-aminosalicílico para influir de forma beneficiosa en la microbiota intestinal y/o tratar la inflamación gastrointestinal
|
|
US10182994B2
(en)
|
2014-06-10 |
2019-01-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
EP3267875A4
(en)
|
2015-03-12 |
2018-12-05 |
Chrono Therapeutics Inc. |
Craving input and support system
|
|
US9993426B2
(en)
|
2015-09-15 |
2018-06-12 |
C. B. Fleet Company, Inc. |
Bisacodyl compositions and delivery apparatus
|
|
US10532046B2
(en)
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
EP3558267B1
(en)
*
|
2016-12-20 |
2023-04-26 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
EP3807260B1
(en)
|
2018-06-15 |
2024-09-18 |
R. J. Reynolds Tobacco Company |
Purification of nicotine
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|